Genmab
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
GMAB | CO
Overview
Corporate Details
- ISIN(s):
- DK0010272202 (+2 more)
- LEI:
- 529900MTJPDPE4MHJ122
- Country:
- Denmark
- Address:
- Carl Jacobsens Vej 30, 2500 Valby
- Website:
- https://www.genmab.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genmab is an international biotechnology company focused on creating and developing differentiated antibody therapeutics for the treatment of cancer and other serious diseases. The company leverages its proprietary antibody science and pioneering technology platforms to innovate next-generation treatments. Genmab's core activities involve the discovery, development, and commercialization of antibody-based products, often in collaboration with strategic partners. Its purpose is to improve the lives of patients by harnessing the power of antibodies to transform medical care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-19 18:55 |
Regulatory News Service
|
English | 206.6 KB | ||
| 2025-11-19 18:55 |
Director's Dealing
|
English | 7.0 KB | ||
| 2025-11-18 20:58 |
Share Issue/Capital Change
|
English | 176.0 KB | ||
| 2025-11-18 20:58 |
Share Issue/Capital Change
|
English | 7.8 KB | ||
| 2025-11-18 17:30 |
Regulatory News Service
|
English | 244.6 KB | ||
| 2025-11-18 17:30 |
Regulatory News Service
|
English | 27.2 KB | ||
| 2025-10-14 12:23 |
Earnings Release
|
English | 216.5 KB | ||
| 2025-10-14 12:23 |
Earnings Release
|
English | 7.7 KB | ||
| 2025-09-29 07:08 |
M&A Activity
|
English | 25.9 KB | ||
| 2025-09-29 07:08 |
M&A Activity
|
English | 234.3 KB | ||
| 2025-09-23 15:18 |
Major Shareholding Notification
|
English | 175.3 KB | ||
| 2025-09-23 15:18 |
Major Shareholding Notification
|
English | 7.2 KB | ||
| 2025-09-23 15:18 |
Major Shareholding Notification
|
English | 2.9 MB | ||
| 2025-09-09 20:57 |
Director's Dealing
|
English | 7.1 KB | ||
| 2025-09-09 20:57 |
Director's Dealing
|
English | 202.5 KB |
Automate Your Workflow. Get a real-time feed of all Genmab filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genmab
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genmab via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
